KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (KNSA)

(10% Negative) KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (KNSA) Announces Delay in inhibition Trials for recurrent pericarditis Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment